146 related articles for article (PubMed ID: 3110694)
1. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis?
Ota K; Mineshima M; Watanabe N; Naganuma S
Nephrol Dial Transplant; 1987; 2(1):30-3. PubMed ID: 3110694
[TBL] [Abstract][Full Text] [Related]
2. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.
Coronel F; Tornero F; Macia M; Sánchez A; De Oleo P; Naranjo P; Barrientos A
Adv Perit Dial; 1991; 7():35-8. PubMed ID: 1680453
[TBL] [Abstract][Full Text] [Related]
5. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and changes of peritoneal function in CAPD and APD patients].
Yokoyama K
Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):259-70. PubMed ID: 8196223
[TBL] [Abstract][Full Text] [Related]
8. [Type III procollagen N-peptide and hyaluronate in serum and dialysate of CAPD patients].
Wakabayashi Y; Yamada K; Miura Y; Nakano H; Nishimura M; Tsuchida H; Shigematsu T; Kawaguchi Y; Sakai O
Nihon Jinzo Gakkai Shi; 1997 May; 39(4):408-13. PubMed ID: 9198363
[TBL] [Abstract][Full Text] [Related]
9. CAPD with preservation of ultrafiltration capacity in infants and young children during the first 18 months of treatment.
van Beek R; Schröder CH; de Jong MC; Monnens LA
Helv Paediatr Acta; 1988 Aug; 43(1-2):33-40. PubMed ID: 3170247
[TBL] [Abstract][Full Text] [Related]
10. How long can continuous ambulatory peritoneal dialysis be continued?
Okada K; Takahashi S; Higuchi T; Kinoshita Y; Kikuchi F; Yamauchi T; Yanai M; Kuno T; Nagura Y
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):65-71. PubMed ID: 8336402
[TBL] [Abstract][Full Text] [Related]
11. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
12. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
Drachman R; Niaudet P; Gagnadoux MF; Broyer M
Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
[TBL] [Abstract][Full Text] [Related]
13. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
[TBL] [Abstract][Full Text] [Related]
15. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
17. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
18. Immunologic patterns in CAPD patients with peritonitis.
Lamperi S; Carozzi S
Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
[TBL] [Abstract][Full Text] [Related]
19. Peritoneum: a noble membrane in long-term dialysis treatment.
Barone RJ; Campora MI; Gimenez NS; Ramirez L; Santopietro M; Grbavac D; Pattin M; Panese SA
Adv Perit Dial; 2009; 25():80-4. PubMed ID: 19886323
[TBL] [Abstract][Full Text] [Related]
20. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure].
Ohira S; Abe K; Kon T
Hokkaido Igaku Zasshi; 1984 Jul; 59(4):478-87. PubMed ID: 6386640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
